Cigar Kadoch | BiotechTV

top of page

State of Possible: Cigall Kadoch discusses her pioneering work in chromatin regulation that has led to Foghorn Therapeutics

She describes the science behind chromatin and gene regulation, previews upcoming preclinical data the company will have at AACR for its...

Bright Minds

Mar 26

Transcriptional regulation in disease: opportunities, challenges, and the future

Cigall Kadoch, associate professor and HHMI Investigator, Dana-Farber Cancer Institute and Harvard Medical School, and scientific founder...

The Studio at Kendall Square

Oct 24, 2024

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.

Learn more about Allucent

bottom of page

State of Possible: Cigall Kadoch discusses her pioneering work in chromatin regulation that has led to Foghorn Therapeutics

Transcriptional regulation in disease: opportunities, challenges, and the future

Follow BiotechTV

Sponsors

Sponsor Spotlight